Article
Rapid identification and phenotyping of nonalcoholic fatty liver disease patients using a machine-based approach in diverse healthcare systems.
Clinical and translational science - 1 Jan 2025
Basile Anna O, Verma Anurag, Tang Leigh Anne, Serper Marina, Scanga Andrew, Farrell Ava, Destin Brittney, Carr Rotonya M, Anyanwu-Ofili Anuli, Rajagopal Gunaretnam, Krikhely Abraham, Bessler Marc, Reilly Muredach P, Ritchie Marylyn D, Tatonetti Nicholas P, Wattacheril Julia
Abstract excerpt
Nonalcoholic fatty liver disease (NAFLD) is the most common global cause of chronic liver disease and remains under-recognized within healthcare systems. Therapeutic interventions are rapidly advancing for its inflammatory phenotype, nonalcoholic steatohepatitis (NASH) at all stages of disease. Diagnosis codes alone fail to recognize and stratify at-risk patients accurately. Our work aims to rapidly identify...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
